Whether you are big or small, an investor or a life science company, a service provider, a manufacturer or a research intensive company, the power of your partnerships will determine your success. For decades now, we have seen a trend of growing openness in our industry, along with an increasing interdependence and specialization. The most successful life science hot spots globally are characterized by this openness, the will to partner up and the ability to do it in a clever way, each actor focusing on what they do best.

In the Nordics, we believe this is one of the keys to our success. Big companies accessing new, disruptive ideas from interacting with entrepreneurial minds of the innovative SMEs. SMEs sharing competence and resources with each other in ground breaking new ways. And the big pharmas, biotechs, medtechs (or any type of tech actually) partnering up with each other to push the frontiers of innovation together, as sector convergence make it futile to even try to stick traditional labels to the companies. Same goes for investors, being able to syndicate with those complementary to your own resources, be it capital or intelligence, is what creates true Intelligent Capital, the life nerve of successful life science ecosystems everywhere.

In the Grand Opening of Nordic Life Science Days 2022, we will explore the various ways to successfully power up through partnerships together with Karin Conde-Knape, Senior Vice President – Global Drug Discovery  at Novo Nordisk and five companies who cracked the code to successful partnerships, one from each Nordic country. Thus illustrating the impressive power up this region is experiencing from coming together as one.